This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Major Depression
and you are
between 19 and 70
years old
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

In order to explore the effect of repetitive TMS, which has shown to be effective in intractable depression, we will examine resting-state, default-mode network functional connectivity in patients with major depression. We will use a double-blind, sham-controlled design. Our target sample size is 60(30 patients will be treated by active rTMS, the other 30 will be treated by sham rTMS). We will apply 10-day course of 10 Hz rTMS on left dorsolateral prefrontal cortex of the subjects.

Provided treatments

  • Device: repetitive transcranial magnetic stimulation(rTMS)
  • Device: Sham repetitive transcranial magnetic stimulation(rTMS)

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01325831. The sponsor of the trial is Yonsei University and it is looking for 44 volunteers for the current phase.
Official trial title:
Change of Dopamine Pathway After rTMS Treatment in Major Depressive Disorder